157 related articles for article (PubMed ID: 17335515)
1. Unusual macular degeneration following breast cancer.
Margolis R; Budd GT; Singh AD
Acta Ophthalmol Scand; 2007 Sep; 85(6):686-7. PubMed ID: 17335515
[No Abstract] [Full Text] [Related]
2. Regression of choroidal metastases from breast carcinoma using aromatase inhibitors.
Manquez ME; Shields CL; Karatza EC; Shields JA
Br J Ophthalmol; 2005 Jun; 89(6):776-7. PubMed ID: 15923523
[No Abstract] [Full Text] [Related]
3. Breast cancer (metastatic).
Stebbing J; Crane J; Gaya A
Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
[No Abstract] [Full Text] [Related]
4. Regression of chronic lymphocytic leukemia with aromatase inhibitor-letrozole?
Paydas S
Leuk Res; 2009 Apr; 33(4):566-7. PubMed ID: 18585780
[No Abstract] [Full Text] [Related]
5. The FACE trial: letrozole or anastrozole as initial adjuvant therapy?
Jonat W; Mundhenke C
Cancer Invest; 2007 Feb; 25(1):14-8. PubMed ID: 17364552
[TBL] [Abstract][Full Text] [Related]
6. Choroidal metastasis in a patient with disseminated breast cancer: hormonal therapy-induced regression.
El-Saify WM
Breast J; 2006; 12(5):490-2. PubMed ID: 16958973
[No Abstract] [Full Text] [Related]
7. Choroidal metastasis presenting as a painful red eye: clinicopathologic report.
Veckeneer M; Leys A; Van Ginderdeuren R; Verstrepen S; Van Garsse L; Missotten L
Bull Soc Belge Ophtalmol; 1997; 265():7-17. PubMed ID: 9479815
[TBL] [Abstract][Full Text] [Related]
8. Regression of choroidal metastasis from breast carcinoma following Letrozole therapy.
Venkatesh P; Garg S
Clin Exp Ophthalmol; 2007 Jul; 35(5):492-4. PubMed ID: 17651258
[TBL] [Abstract][Full Text] [Related]
9. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J
Breast J; 2009; 15(4):435-7. PubMed ID: 19470131
[No Abstract] [Full Text] [Related]
10. Letrozole for brain and scalp metastases from breast cancer--a case report.
Madhup R; Kirti S; Bhatt ML; Srivastava PK; Srivastava M; Kumar S
Breast; 2006 Jun; 15(3):440-2. PubMed ID: 16169225
[TBL] [Abstract][Full Text] [Related]
11. A review of the BIG results: the Breast International Group 1-98 trial analyses.
Doughty JC
Breast; 2008 Jan; 17 Suppl 1():S9-S14. PubMed ID: 18279765
[TBL] [Abstract][Full Text] [Related]
12. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
Stilwill SE; Cooper BC
J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
[TBL] [Abstract][Full Text] [Related]
13. Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors.
Torrisi R; Dellapasqua S; Ghisini R; Viale G; Veronesi P; Luini A; Intra M; Peruzzotti G; Rocca A; Balduzzi A; Cardillo A; Goldhirsch A; Colleoni M
Breast; 2008 Dec; 17(6):654-60. PubMed ID: 18595702
[TBL] [Abstract][Full Text] [Related]
14. Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.
Bellone S; Shah HR; McKenney JK; Stone PJ; Santin AD
Am J Obstet Gynecol; 2008 Sep; 199(3):e7-e10. PubMed ID: 18550023
[TBL] [Abstract][Full Text] [Related]
15. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
Monnier AM
Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
[TBL] [Abstract][Full Text] [Related]
16. Excellent response to letrozole in brain metastases from breast cancer.
Goyal S; Puri T; Julka PK; Rath GK
Acta Neurochir (Wien); 2008 Jun; 150(6):613-4; discussion 614-5. PubMed ID: 18458809
[TBL] [Abstract][Full Text] [Related]
17. [Breast cancer metastases].
Français-Maury C; Frau E
J Fr Ophtalmol; 2002 Oct; 25(8):861-2. PubMed ID: 12471357
[No Abstract] [Full Text] [Related]
18. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy.
Akashi-Tanaka S; Omatsu M; Shimizu C; Ando M; Terada K; Shien T; Kinoshita T; Fujiwara Y; Seki K; Hasegawa T; Fukutomi T
Breast; 2007 Oct; 16(5):482-8. PubMed ID: 17418576
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
Brufsky A; Bundred N; Coleman R; Lambert-Falls R; Mena R; Hadji P; Jin L; Schenk N; Ericson S; Perez EA;
Oncologist; 2008 May; 13(5):503-14. PubMed ID: 18515735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
